Residency Program Director
Previous Year Residents
  • Rachel Klosko

    Clinical Assistant Faculty Member, Binghamton School of Pharmacy, Binghamton, New York
  • Rachael Eaton

    Clinical Pharmacy Specialist- Vascular Surgery, The Ohio State Wexner Medical Center
  • Rachel Lavelle

    Clinical Pharmacy Specialist – Cardiology, University of Chicago Medicine, Chicago, IL
  • Daniel Galipeau

    Cardiology Clinical Pharmacist, UK HealthCare, Lexington, Kentucky
  • Sara Johnson

    Cardiology Clinical Pharmacist, The University of Kansas Health System
  • Maya Holsen

    Cardiology Critical Care Specialty Pharmacist and Faculty, University of Buffalo
  • Joshua Jacobs

    Cardiology Clinical Pharmacist, The University of Utah
  • Shea Macielak

    Staff Pharmacist, Mayo Clinic, Rochester, MN
  • Poonam Jewani

    Clinical Pharmacist, Cardiology, Northwestern Memorial Hospital, Chicago, IL
  • Brooke Stanton

    Clinical Specialist – Cardiology/Critical Care, SSM Health, St. Louis University Hospital, St. Louis, MO
  • Libby Orzel

    Medical Science Liaison, Sanofi
  • Christopher Min

    Clinical Pharmacist, Hospital of the University of Pennsylvania, Philadelphia, PA 
  • Heidi Brink

    Pharmacy Coordinator, Cardio/Pulmonary Transplant, Nebraska Medical Center
  • Bola Lawuyi

    Cardiology Clinical Specialist , Medstar Washington Hospital, Washington DC

About the PGY2 Cardiology Residency Program


The PGY2 pharmacy residency program builds on Doctor of Pharmacy (Pharm.D.) education and PGY1 pharmacy residency program to contribute to the development of clinical pharmacists in advanced or specialized practice. PGY2 residencies provide residents with opportunities to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge incorporating both into the provision of patient care that improves medication therapy. Residents who successfully complete an accredited PGY2 pharmacy residency should possess competencies that qualify them for clinical pharmacist and/or faculty positions and position them to be eligible for attainment of board certification in that practice area (when board certification for the practice area exists).

Residency Sites

As one of America’s top ranked academic medical centers, the mission of The Ohio State University Wexner Medical Center (OSUWMC) is to improve people’s lives through innovation in research, education, and patient care. OSUWMC is a 1,506 bed multi-hospital delivery system recognized in 2018 as one of “America’s Best Hospitals” for excellence in ten specialties by US News and World Report based on quality, outcomes, and reputation.

Read about the sites


The Ross Heart Hospital

The Richard M. Ross Heart Hospital at The OSUWMC is a 150-bed, comprehensive, cardiovascular center which specializes in the multidisciplinary care of patients in areas of  cardiovascular surgery, heart failure, pulmonary hypertension, heart and lung transplant , acute coronary syndromes, mechanical circulatory support  and electrophysiology. Each floor is dedicated to a specific service and combines the latest technology with patient –focused care to create the best possible healing environment. Our staff manages patients across a diverse spectrum of care, extending from critical care to the ambulatory setting.  Ohio State’s Heart and Vascular Center is considered one of the nation’s best hospitals for cardiology and heart surgery, as ranked by U.S. News & World Report, the only central Ohio hospital to earn a spot on the list. Our philosophy strongly supports working as a team to provide the right care to the right patient at the right time, in a safe and secure environment.



The PGY2 cardiology residency provides the essential skills needed to be proficient in providing pharmaceutical care to patients with various cardiac vascular diseases or procedures such as: acute coronary syndromes, electrophysiology, heart failure and cardiothoracic surgery. Residents will strengthen his/her clinical acumen and communication skills through completion of at least one rotation in the required areas of: Acute Coronary Syndromes/Coronary ICU, Cardiovascular ICU, Electrophysiology, General Cardiology, Heart Failure/Heart Transplant and Thoracic Transplant. Most of the services are teaching services and may be composed of an attending cardiologist or cardiovascular intensivist, cardiology/anesthesia/surgery fellow, and house staff including residents, interns, or nurse practitioners. Elective rotations are determined based on the resident’s individual goals and at the discretion of the Director.

Key Preceptors

Danielle Blais, PharmD, BCPS
Acute Coronary Syndrome/CICU

Mike Boyd, PharmD, BCPS
Electrophysiology/ Cardiology

Pam Burcham, PharmD, BCPS
Cardiothoracic Surgery/Mechanical Circulatory Support

Kevin Kissling, PharmD, BCPS
Advanced Heart Failure/Heart Transplant

Kerry Pickworth, PharmD, FCCP
Cardiology/Heart Failure

Alan Rozycki, PharmD, BCCCP
Cardiothoracic Surgery/Mechanical Circulatory Support

Selected Resident Research

  • Incidence and time to cytomegalovirus disease in cardiac transplant recipients receving induction immunosuppression with antithymocyte globulin- Jewani P, Kissling K
  • Sotalol initiation in patients with a prolonged corrected QT interval:  experiences from an academic medical center- Stanton B, Boyd JM
  • Risk factors associated with subtherapeutic anticoagulation with Bivalirudin – Herman L
  • Switching From Ticagrelor to Clopidogrel: Outcomes after Percutaneous Coronary Intervention-Min C
  • Comparison of the safety of adenosine and regadenoson in outpatient cardiac stress testing. Pharmacother 2015;35(12):1117-1123.- Brink H, Dickerson J, Stephens J, Pickworth K
  • Desensitization as an approach to the clinical conundrum of cardiovascular patients with aspirin allergy-Lawuyi B, Blais D
  • Thirty day hospital readmission for thromboembolic complications in patients with potential heparin-induced thrombocytopenia- Kazmi H, Kissling K, Abel E
  • Efficacy of prophylactic oral amiodarone and intravenous magnesium in decreasing the incidence of post-operative atrial fibrillation in cardiac surgery- Varnado S, Burcham P, Blais D, Abel E

Benefits and Additional Requirements

Application Deadline:  January 2, 2021

Start Date: July 1

Annual Salary – $48,500

Vacation Days – 10 days

Staffing Requirement – 20 weekends a year

Completion of a Major Research Project


Download PDF